Purdue Pharma and its subsidiaries develop, manufacture and market medications and consumer health products to meet the evolv ... ing needs of healthcare professionals, patients, consumers and caregivers. Purdue’s Plan of Reorganization received bankruptcy court approval, paving the way for the delivery of billions in value to communities across the country to fund programs specifically for abatement of the opioid crisis. Substantially all of Purdue’s assets will be transferred to a new post-emergence company with a public-minded mission. This new company will be governed by new independent board members, and will operate in a responsible and sustainable manner taking into account long-term public health interests relating to the opioid crisis. The company will continue serving patients and consumers who rely on its medicines and products, pursuing its pipeline, and introducing medicines that will help save and improve lives. read more